MedImmune Inc. regulatory update

U.S. Patent No. 5,582,827 covering RespiGam

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE